Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06026124 · ClinicalTrials.gov registry record · NA

Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading

A NA study of Developmental Language Disorder and Language Development, sponsored by Purdue University.

Completed
Registry status
NA
Development phase
27
Enrollment target
2
Study locations

NCT06026124: Completed NA study of Developmental Language Disorder and Language Development, sponsored by Purdue University.

NCT06026124 is a NA study of Developmental Language Disorder and Language Development that has completed, run by Purdue University. The registered enrollment target is 27 participants, below the 181-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06026124, a NA study of Developmental Language Disorder and Language Development, has completed, sponsored by Purdue University.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
2
Study locations

Study Summary

Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the children's academic, social, and eventual economic well-being. Word learning is one of the principal weaknesses in these children. This project focuses on the word learning abilities of four- and five-year-old children with DLD. The goal of the project is to build on the investigators' previous work to determine whether, as has been found thus far, special benefits accrue when these children must frequently recall newly introduced words during the course of learning. In this study, the investigators seek to replicate the advantage that repeated retrieval holds over simple exposure to the words and to demonstrate an increase in children's absolute levels of learning by implementing retrieval practice in the context of a story book.

Primary Outcome

Five minutes after second learning session, the child was asked to recall and say the word associated with each novel referent, learned under one of two conditions: a condition in which spaced retrieval trials occurred (RSR) and one in which there were no retrieval trials (RS). Each of the four verbs were tested twice, for a total of 8 recall items per condition.

Interventions

  • BEHAVIORAL Retrieval-based word learning: Repeated Spaced Retrieval condition
  • BEHAVIORAL Retrieval-based word learning: Repeated Study condition

Study Locations (2)

Indiana

  • Purdue University's SLHS laboratories (8445 Keystone Crossing) - Indianapolis
  • Purdue University - West Lafayette

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2022-10-31
Est. Completion 2024-09-17
Phase NA
Purdue University

141 total trials

What the finished NCT06026124 record still lists

NCT06026124 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 181-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (85% lower).

The record links to 3 conditions, with Developmental Language Disorder appearing as the primary indexed condition, and to 2 interventions - of which Retrieval-based word learning: Repeated Spaced Retrieval condition is the first listed.

NCT06026124 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT06026124 about?

NCT06026124 is a clinical study titled "Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading". Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the children's academic, social, and eventual economic well-being. Word learning is one of the principal weak...

What is the current status of trial NCT06026124?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2022-10-31. Estimated completion is 2024-09-17.

What conditions does trial NCT06026124 study?

This clinical trial studies the following conditions: Developmental Language Disorder, Language Development, Specific Language Impairment.

What interventions are being tested in trial NCT06026124?

The interventions under investigation include: Retrieval-based word learning: Repeated Spaced Retrieval condition (BEHAVIORAL), Retrieval-based word learning: Repeated Study condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT06026124?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06026124 being conducted?

This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Language Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06026124's enrollment target sits among peer trials

27 18th of 17 the lowest of 17 other Developmental Language Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Developmental Language Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06026124, the US trial registry maintained by the National Library of Medicine. NCT06026124 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.